ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Ascentage Pharma Group INC.

Official 2024 U.S. DOL Form 5500 summary for Ascentage Pharma Group INC. (Ascentage Pharma Group INC. 401(k) Plan · EIN 81-1034123 · PN 001): $13.24M net assets, 87 active participants, and $46.98 per $10,000 (46.98 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAscentage Pharma Group INC.
Filing IdentifierAscentage Pharma Group INC. 401(k) Plan · EIN 81-1034123 · PN 001
Plan Category & State401(k) Defined Contribution (MD)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$13.24M
Active Participants87
Direct Admin Fee Rate$46.98 per $10,000 (46.98 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderMma Securities, LLC
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI